My DRIV made 700% profit–wow!
UPDATE 10-20 BSX earnings weren’t that bad today, and yet the market does not like medical devices sector, because of the Obama health reform plan–cuts in medicare—so BSX is down -16%–I’m pretty sure STJ will be down on its earnings too. The market doesn’t care what is reported–
SRJ earnings 10-21
STJ at 32.5 prior to 10-21 earnings date–Go long into earnings
STJ shows strong EPS history.
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide.
St. Jude Medical (STJ: NYSE) By Robert W. Baird ($38.24, Oct. 6, 2009)
WE ARE UPGRADING St. Jude Medical (ticker: STJ) to Outperform [from Neutral] with a $41 price target.
The selloff in St. Jude Medical to the $34 area reflects disappointment with the third quarter where currency-neutral revenue growth will be 10%.